Alembic Pharmaceuticals informs about press release

14 May 2021 Evaluate

Alembic Pharmaceuticals has informed that the Company has received US Food & Drug Administration (USFDA) Final Approval for Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg, and 120 mg. In this regard, the company has enclosed a press release on 14th May 2021 regarding the same above.

The above information is a part of company’s filings submitted to BSE.


Alembic Pharma Share Price

840.50 -2.65 (-0.31%)
30-Dec-2025 11:18 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.45
Dr. Reddys Lab 1268.10
Cipla 1487.95
Zydus Lifesciences 903.95
Lupin 2083.80
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×